Subject matters | Details | Categories |
---|---|---|
Health, Industry, Research and Development
|
Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines
|
Policies or Program
|
Aboriginal Affairs, Health
|
Federal Government First Nations and Inuit Health Branch program with respect to health services.
|
Policies or Program
|
Health
|
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
Health, Industry, Research and Development
|
Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
|
Policies or Program
|
Health, Industry
|
o Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
|
Legislative Proposal, Bill or Resolution
|
Health
|
Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
|
Policies or Program
|
Address:
6711 Mississauga Road, suite 600
Mississauga, ON L5N 2W3
Canada
Telephone number:
905-363-8001
Bobby Sutherland, Senior Director, Government Affairs
Gilead Sciences Canada Inc. is not a coalition.
The activities of Gilead Sciences Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Gilead Sciences Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Greg Maceachern | Public offices held
Firm: KAN Strategies